Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Amy, Pierre"'
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:QIM23-136
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::755cf2f8e6004efb29bcb6e19f152fba
https://doi.org/10.6004/jnccn.2022.7176
https://doi.org/10.6004/jnccn.2022.7176
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6cf232638c2daa0a9c0f851c3e07cb59
https://doi.org/10.1016/j.clml.2023.05.005
https://doi.org/10.1016/j.clml.2023.05.005
Autor:
Anp-Bc, Amy Pierre
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Amy Pierre, MSN, ANP-BC, of Flatiron Health and Memorial Sloan Kettering Cancer Center, considers takeaways from a program targeting minority accrual to oncology trials and a study evaluating minority representation in precision oncology trials.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5057027f7d8a5fd0aa7b3e333710e4af
http://europepmc.org/articles/PMC8423186
http://europepmc.org/articles/PMC8423186
Autor:
Maimah, Karmo, Amy, Pierre
Publikováno v:
Journal of the Advanced Practitioner in Oncology. 13:202-204
At the JADPRO Live Virtual 2021 keynote interview, Maimah Karmo, CEO and Founder of the Tigerlily Foundation, spoke with Amy Pierre, MSN, ANP-BC, on her breast cancer experience and drive to establish an organization that educates, advocates for, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7768dfc293703ee7c6df0f20dd51f532
https://doi.org/10.6004/jadpro.2022.13.3.3
https://doi.org/10.6004/jadpro.2022.13.3.3
Autor:
P. Andrew Allred, MS, PA-C, Amy Pierre, MSN, ANP-BC, Meredith Beaton, MSN, RN, Pamela Lee, NP, MSN, Amber Koehler, PA-C
Publikováno v:
Journal of the advanced practitioner in oncology. 13(6)
P. Andrew Allred, MS, PA-C, of Banner MD Anderson Cancer Center, considers data on managing newly diagnosed MM and CAR T-cell therapy in MM. Amy Pierre, MSN, ANP-BC, of MSKCC and Flatiron Health, reviews findings on telemedicine inequities and real-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21c92bafe70639bea47c4117b501d749
https://pubmed.ncbi.nlm.nih.gov/36160061
https://pubmed.ncbi.nlm.nih.gov/36160061
Hematologic Malignancies: ASCO20 Virtual Scientific Program Highlights for the Advanced Practitioner
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c79e2ebd27902b0ad34287c23970d53c
https://pubmed.ncbi.nlm.nih.gov/33552656
https://pubmed.ncbi.nlm.nih.gov/33552656
Autor:
Tiffany H. Williams, Amy Pierre
Publikováno v:
Clinical journal of oncology nursing. 24(4)
The incidence of multiple myeloma in African Americans is two to three times higher than in other ethnicities and is the leading hematologic malignancy in African Americans. Despite the high incidence of multiple myeloma in African American individua
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d089882705bfd792c7ad5c86715638b
https://pubmed.ncbi.nlm.nih.gov/32678364
https://pubmed.ncbi.nlm.nih.gov/32678364
Autor:
Amy Pierre, Joshua Richter
Publikováno v:
Journal of the Advanced Practitioner in Oncology
Amy E. Pierre, MSN, ANP-BC, and Joshua Richter, MD, break down the approved and emerging treatment options for relapsed/refractory multiple myeloma, including mechanisms of action, supporting clinical data, and associated adverse events, and discuss
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::997abe5552b1e56a1f4d6abe8af131bf
https://doi.org/10.6004/jadpro.2020.11.3.18
https://doi.org/10.6004/jadpro.2020.11.3.18
Autor:
Erlene K. Seymour, Mustafa Ascha, Xiaoliang Wang, Niquelle Brown Wadé, Kathleen Maignan, Pritesh R. Patel, Brian C.-H. Chiu, Gregory S. Calip, Natalia Neparidze, Amy Pierre, Karen Sweiss, Siyang Leng
Publikováno v:
Blood. 138:4121-4121
Background: The incidence of multiple myeloma (MM) and enrichment of cytogenetic abnormalities differ significantly between racial/ethnic groups in the US, and their significance in determining myeloma progression and survival is not well understood.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f3ae265e6c485d563baf097167b2454
https://doi.org/10.1182/blood-2021-152774
https://doi.org/10.1182/blood-2021-152774
Publikováno v:
Seminars in Oncology Nursing. 33:332-347
Objective To review disease-related symptoms and side effects of treatment in patients with multiple myeloma (MM). Data Sources Peer-reviewed articles, research studies, and clinical guidelines. Conclusion New therapies provide patients with extended
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4be4747afc2c63b26ed5b5c07e44021
https://doi.org/10.1016/j.soncn.2017.05.008
https://doi.org/10.1016/j.soncn.2017.05.008